AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10694624 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate lukewarm (20 degrees C) cardioplegia
Number of subjects: 135
Study 10694624 — intervention group
Group type: COMPARATOR
Intervention: Cold (8 degrees C) cardioplegia
Number of subjects: 135
Study 10694624 — intervention group
Group type: COMPARATOR
Intervention: Warm (37 degrees C) cardioplegia
Number of subjects: 135
Study 9381445 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter arguing for reduction of daily benzodiazepine intake
Number of subjects: 169
Study 9381445 — intervention group
Group type: COMPARATOR
Intervention: Control group (no letter)
Number of subjects: 169
Study 8410962 — intervention group
Group type: EXPERIMENTAL
Intervention: alprazolam (1 mg) and alcohol (0.5 g/kg)
Number of subjects: 48
Study 8410962 — intervention group
Group type: EXPERIMENTAL
Intervention: alprazolam (1 mg) and placebo drink
Number of subjects: 48
Study 8410962 — intervention group
Group type: EXPERIMENTAL
Intervention: placebo capsule and alcohol (0.5 g/kg)
Number of subjects: 48
Study 8410962 — intervention group
Group type: COMPARATOR
Intervention: placebo capsule and placebo drink
Number of subjects: 48
Study 3101616 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 10
Study 3101616 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow's milk formula (untreated)
Number of subjects: 10
Study 3101616 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow's milk formula (treated with lactase)
Number of subjects: 10
Study 31096953 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Doppler ultrasound
Number of subjects: 93
Study 31096953 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic osteophyte score
Number of subjects: 93
Study 31096953 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic erosion
Number of subjects: 93
Study 27864822 — intervention group
Group type: EXPERIMENTAL
Intervention: Home‐based hand‐arm bimanual intensive therapy (H‐HABIT; n=12)
Number of subjects: 24
Study 27864822 — intervention group
Group type: COMPARATOR
Intervention: Lower‐limb functional intensive training (LIFT-control; n=12)
Number of subjects: 24
Study 25041071 — intervention group
Group type: EXPERIMENTAL
Intervention: DECISION+2 (two-hour online tutorial, two-hour workshop, and decision support tools)
Number of subjects: 359
Study 25041071 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 359
Study 25041071 — intervention group
Group type: EXPERIMENTAL
Intervention: DECISION+2
Number of subjects: 359
Study 24669687 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery plus radiotherapy (S+R group)
Number of subjects: 59
Study 24669687 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (S group)
Number of subjects: 59
Study 21219602 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention group
Number of subjects: 507
Study 21219602 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 507
Study 19324530 — intervention group
Group type: EXPERIMENTAL
Intervention: oxcarbazepine (1,000‐2,400 mg/day)
Number of subjects: 60
Study 19324530 — intervention group
Group type: COMPARATOR
Intervention: divalproex (750‐2,000 mg/day)
Number of subjects: 60
Study 17684201 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA oil (7.5 g DHA oil/d, equivalent to 3 g DHA/d)
Number of subjects: 34
Study 17684201 — intervention group
Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 34
Study 15113640 — intervention group
Group type: EXPERIMENTAL
Intervention: Bidding game format
Number of subjects: 106
Study 15113640 — intervention group
Group type: COMPARATOR
Intervention: Open-ended format
Number of subjects: 106
Study 15113640 — intervention group
Group type: COMPARATOR
Intervention: Payment scale format
Number of subjects: 106
Study 11719729 — intervention group
Group type: EXPERIMENTAL
Intervention: S(+)‐ketamine
Number of subjects: 10
Study 11719729 — intervention group
Group type: EXPERIMENTAL
Intervention: Racemic ketamine
Number of subjects: 10
Study 11719729 — intervention group
Group type: EXPERIMENTAL
Intervention: R(‐)‐ketamine
Number of subjects: 10
Study 10088202 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 5 mg once a day for 4 weeks
Number of subjects: 9
Study 10088202 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol 95 mg once a day for 4 weeks
Number of subjects: 9
Study 7529981 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg/day prednisolone
Number of subjects: 10
Study 7529981 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.0 mg/day prednisolone
Number of subjects: 10
Study 2977271 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting D-Trp-6 LH-RH
Number of subjects: 113
Study 30704025 — intervention group
Group type: EXPERIMENTAL
Intervention: KiVa anti-bullying program (n = 536)
Number of subjects: 1051
Study 30704025 — intervention group
Group type: COMPARATOR
Intervention: Control condition (n = 516)
Number of subjects: 1051
Study 29141124 — intervention group
Group type: EXPERIMENTAL
Intervention: Valbenazine 80 mg
Number of subjects: 198
Study 29141124 — intervention group
Group type: EXPERIMENTAL
Intervention: Valbenazine 40 mg
Number of subjects: 198
Study 29141124 — intervention group
Group type: COMPARATOR
Intervention: Placebo (during initial 6-week period)
Number of subjects: 198
Study 29141124 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Valbenazine treatment
Number of subjects: 198
Study 25660012 — intervention group
Group type: EXPERIMENTAL
Intervention: Krakow stitch (KS)
Number of subjects: 18
Study 25660012 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple suture (SS)
Number of subjects: 18
Study 25660012 — intervention group
Group type: COMPARATOR
Intervention: Lasso loop (LL)
Number of subjects: 18
Study 23374797 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoldopam (0.1 μg/kg/min for 24 hours)
Number of subjects: 90
Study 23374797 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 21200340 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained FDI's MVC
Number of subjects: 12
Study 21200340 — intervention group
Group type: EXPERIMENTAL
Intervention: Untrained FDI's MVC
Number of subjects: 12
Study 21200340 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticospinal excitability in iM1
Number of subjects: 12
Study 21200340 — intervention group
Group type: EXPERIMENTAL
Intervention: Interhemispheric inhibition
Number of subjects: 12
Study 21200340 — intervention group
Group type: COMPARATOR
Intervention: Nonexercising control group
Number of subjects: 12
Study 19650803 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment block (FIC) with 30 ml of ropivacaine 3.75 mg/ml (112.5 mg) 20 min before spinal block
Number of subjects: 40
Study 19650803 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment block (FIC)
Number of subjects: 40
Study 19650803 — intervention group
Group type: COMPARATOR
Intervention: Intravenous analgesia with alfentanil (IVA) - bolus dose of 10 microg/kg, continuous infusion of 0.25 microg/kg/min starting 2 min before spinal block
Number of subjects: 40
Study 19650803 — intervention group
Group type: COMPARATOR
Intervention: Intravenous analgesia with alfentanil (IVA)
Number of subjects: 40
Study 17669280 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 0
Study 17669280 — intervention group
Group type: COMPARATOR
Intervention: Omission of radiotherapy
Number of subjects: 0
Study 15209007 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily iron supplementation
Number of subjects: 353
Study 15209007 — intervention group
Group type: EXPERIMENTAL
Intervention: Once weekly iron supplementation
Number of subjects: 353
Study 15209007 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 353
Study 14512036 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet designed for patients with diabetes (DD)
Number of subjects: 11
Study 14512036 — intervention group
Group type: COMPARATOR
Intervention: Standard diet (SD)
Number of subjects: 11
Study 14512036 — intervention group
Group type: COMPARATOR
Intervention: Fibre-enriched diet (FD)
Number of subjects: 11
Study 14512036 — intervention group
Group type: COMPARATOR
Intervention: Standard diets (SD and FD)
Number of subjects: 11
Study 9971864 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy (transfusions if hemoglobin < 7.0 g/dL, maintained at 7.0 to 9.0 g/dL)
Number of subjects: 838
Study 9971864 — intervention group
Group type: COMPARATOR
Intervention: Liberal transfusion strategy (transfusions if hemoglobin < 10.0 g/dL, maintained at 10.0 to 12.0 g/dL)
Number of subjects: 838
Study 9971864 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive transfusion strategy
Number of subjects: 838
Study 9971864 — intervention group
Group type: COMPARATOR
Intervention: Liberal transfusion strategy
Number of subjects: 838
Study 7573591 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy
Number of subjects: 32
Study 7573591 — intervention group
Group type: COMPARATOR
Intervention: Supportive psychotherapy
Number of subjects: 32
Study 2099731 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucaine
Number of subjects: 50
Study 2099731 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucaine without oxethazaine
Number of subjects: 50
Study 2099731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 6932992 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG and monthly chemotherapy
Number of subjects: 86
Study 6932992 — intervention group
Group type: COMPARATOR
Intervention: Weekly irradiated allogeneic blast cells
Number of subjects: 86
Study 6932992 — intervention group
Group type: COMPARATOR
Intervention: Not achieving complete remission
Number of subjects: 86
Study 6932992 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients alive without relapse
Number of subjects: 86
Study 31156155 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular + NPH Insulin
Number of subjects: 100
Study 31156155 — intervention group
Group type: COMPARATOR
Intervention: Novo‐rapid + Levemir Insulin
Number of subjects: 100
Study 28973074 — intervention group
Group type: EXPERIMENTAL
Intervention: SAbR plus maintenance chemotherapy
Number of subjects: 29
Study 28973074 — intervention group
Group type: COMPARATOR
Intervention: Maintenance chemotherapy alone
Number of subjects: 29
Study 27143035 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI groups
Number of subjects: 1664
Study 27143035 — intervention group
Group type: COMPARATOR
Intervention: Low BMI/High fitness group
Number of subjects: 1664
Study 27143035 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitness
Number of subjects: 1664
Study 27143035 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese girls
Number of subjects: 1664
Study 27143035 — intervention group
Group type: EXPERIMENTAL
Intervention: Girls
Number of subjects: 1664
Study 27143035 — intervention group
Group type: EXPERIMENTAL
Intervention: Boys
Number of subjects: 1664
Study 27143035 — intervention group
Group type: EXPERIMENTAL
Intervention: LP-IR
Number of subjects: 1664
Study 24290148 — intervention group
Group type: EXPERIMENTAL
Intervention: Four double-page questionnaire
Number of subjects: 2269
Study 24290148 — intervention group
Group type: COMPARATOR
Intervention: Two double-page questionnaire
Number of subjects: 2269
Study 24290148 — intervention group
Group type: EXPERIMENTAL
Intervention: One double-page questionnaire
Number of subjects: 2269
Study 22858181 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambrisentan
Number of subjects: 393
Study 22858181 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 393
Study 20223094 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate (1000 mg/day)
Number of subjects: 97
Study 20223094 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 17561969 — intervention group
Group type: EXPERIMENTAL
Intervention: Color Doppler ultrasonography
Number of subjects: 44
Study 17561969 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic injection sclerotherapy (EIS)
Number of subjects: 44
Study 15770383 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral internal sphincterotomy in addition to Milligan‐Morgan hemorrhoidectomy
Number of subjects: 78
Study 15770383 — intervention group
Group type: COMPARATOR
Intervention: Milligan‐Morgan hemorrhoidectomy alone
Number of subjects: 78
Study 12222646 — intervention group
Group type: EXPERIMENTAL
Intervention: True interference group (artificial interferences introduced)
Number of subjects: 47
Study 12222646 — intervention group
Group type: COMPARATOR
Intervention: Placebo interference group (simulated interferences)
Number of subjects: 47
Study 10223757 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic injection (1 to 2 ml of 2 percent lignocaine) during triple rubber band ligation
Number of subjects: 101
Study 10223757 — intervention group
Group type: COMPARATOR
Intervention: Control group (no local anesthetic injection) during triple rubber band ligation
Number of subjects: 101
Study 8847153 — intervention group
Group type: EXPERIMENTAL
Intervention: Brodimoprim 400 mg OD on the first day followed by 200 mg OD for 2 days
Number of subjects: 203
Study 8847153 — intervention group
Group type: COMPARATOR
Intervention: Norfloxacin 400 mg BID
Number of subjects: 203
Study 29533540 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Misgav‐Ladach method (MML)
Number of subjects: 252
Study 29533540 — intervention group
Group type: COMPARATOR
Intervention: Pfannenstiel-Kerr method (PK)
Number of subjects: 252
Study 29533540 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 252
Study 28534476 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Message Service (SMS) management
Number of subjects: 350
Study 28534476 — intervention group
Group type: COMPARATOR
Intervention: Conventional directly observed therapy (DOT)
Number of subjects: 350
Study 26448482 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental concerns about treatment efficacy and side effects
Number of subjects: 1820
Study 26448482 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental concerns about child health
Number of subjects: 1820
Study 26448482 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental concerns about psychosocial function
Number of subjects: 1820
Study 26448482 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental education and parenting style
Number of subjects: 1820
Study 23222075 — intervention group
Group type: EXPERIMENTAL
Intervention: Ballistic Bench Press (BBP)
Number of subjects: 20
Study 23222075 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy Resistance Training (HRT)
Number of subjects: 20
Study 23222075 — intervention group
Group type: COMPARATOR
Intervention: Comparison of BBP and HRT
Number of subjects: 20
Study 21359598 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe monotherapy 10 mg/day (EZT group)
Number of subjects: 60
Study 21359598 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic lifestyle changes (TLC group)
Number of subjects: 60
Study 18554825 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant-partner psychological aggression
Number of subjects: 489
Study 18554825 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant-partner physical aggression
Number of subjects: 489
Study 18554825 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant-partner injury
Number of subjects: 489
Study 18554825 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner-to-participant psychological aggression
Number of subjects: 489
Study 18554825 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner-to-participant physical aggression
Number of subjects: 489
Study 18554825 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner-to-participant injury
Number of subjects: 489
Study 16860035 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme replacement therapy with human recombinant alpha‐L‐iduronidase
Number of subjects: 5
Study 12884356 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion-weighted imaging (DWI) with a modified pulse sequence and breath holding, using five different b gradient factor values (50 to 250 s/mm(2)).
Number of subjects: 28
Study 12884356 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (no specific intervention mentioned).
Number of subjects: 28
Study 10844053 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (300 mg daily) and nicotinamide (300 mg daily) for 3 months
Number of subjects: 11
Study 10844053 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 9093632 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine-Chlorpheniramine combination
Number of subjects: 112
Study 9093632 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 112
Study 3545785 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrabamate (three 300 mg tablets/day)
Number of subjects: 68
Study 3545785 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 3545785 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrabamate
Number of subjects: 68
Study 21255807 — intervention group
Group type: EXPERIMENTAL
Intervention: α-lipoic acid 600 mg via intravenous infusion once a day for 3 weeks
Number of subjects: 60
Study 21255807 — intervention group
Group type: COMPARATOR
Intervention: Untreated experimental group
Number of subjects: 60
Study 21255807 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 60
Study 29931320 — intervention group
Group type: EXPERIMENTAL
Intervention: Estetrol (E4) 20 mg/d
Number of subjects: 45
Study 29931320 — intervention group
Group type: EXPERIMENTAL
Intervention: Estetrol (E4) 40 mg/d
Number of subjects: 45
Study 29931320 — intervention group
Group type: EXPERIMENTAL
Intervention: Estetrol (E4) 60 mg/d
Number of subjects: 45
Study 29931320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 27837656 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (exposed to negative feedback)
Number of subjects: 190
Study 27837656 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (exposed to positive feedback)
Number of subjects: 190
Study 27837656 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 190
Study 27837656 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (general findings)
Number of subjects: 190
Study 27837656 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (vulnerable children)
Number of subjects: 190
Study 25533727 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily weight tracking
Number of subjects: 339
Study 25533727 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly weight tracking
Number of subjects: 339
Study 25533727 — intervention group
Group type: COMPARATOR
Intervention: No weight tracking
Number of subjects: 339
Study 23869537 — intervention group
Group type: EXPERIMENTAL
Intervention: Human-derived milk fortifier (HDMF)
Number of subjects: 164
Study 23869537 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal human milk (MHM)
Number of subjects: 164
Study 23869537 — intervention group
Group type: EXPERIMENTAL
Intervention: Early preterm maternal human milk (MHM)
Number of subjects: 164
Study 23869537 — intervention group
Group type: COMPARATOR
Intervention: Donor human milk (DHM)
Number of subjects: 164
Study 23869537 — intervention group
Group type: EXPERIMENTAL
Intervention: Early maternal human milk (MHM)
Number of subjects: 164
Study 21990405 — intervention group
Group type: EXPERIMENTAL
Intervention: ABVD
Number of subjects: 76
Study 21990405 — intervention group
Group type: EXPERIMENTAL
Intervention: MOPP/EBV/CAD (MEC)
Number of subjects: 76
Study 21990405 — intervention group
Group type: COMPARATOR
Intervention: Stanford V (StV)
Number of subjects: 76
Study 18475028 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural injection of 1% ropivacaine and general anesthesia (epidural and general group, n=12)
Number of subjects: 24
Study 18475028 — intervention group
Group type: COMPARATOR
Intervention: Epidural injection of saline and general anesthesia (general group, n=12)
Number of subjects: 24
Study 16552408 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail intervention
Number of subjects: 1801
Study 16552408 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone intervention
Number of subjects: 1801
Study 16552408 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1801
Study 12588386 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment
Number of subjects: 97
Study 12588386 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 97
Study 11326160 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotiam (1 g) and Metronidazole (0.5 g) intravenously 30 min before surgery
Number of subjects: 199
Study 11326160 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin (2 g) intravenously 30 min before surgery
Number of subjects: 199
Study 8781317 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa (IFN‐alpha) 5 MU/m2 three times per week for 12 weeks
Number of subjects: 61
Study 8781317 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroids plus interferon
Number of subjects: 61
Study 8781317 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 61
Study 1731672 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual shaving
Number of subjects: 1980
Study 1731672 — intervention group
Group type: COMPARATOR
Intervention: Electrical clipping
Number of subjects: 1980
Study 1731672 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine solution (0.5%) irrigation
Number of subjects: 1980
Study 1731672 — intervention group
Group type: COMPARATOR
Intervention: Saline solution irrigation
Number of subjects: 1980
Study 1731672 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative debridement with closed tube irrigation
Number of subjects: 1980
Study 1731672 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary open wound procedures followed by delayed muscular flap closures
Number of subjects: 1980
Study 1731672 — intervention group
Group type: EXPERIMENTAL
Intervention: Open drainage
Number of subjects: 1980
Study 6398725 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesterolone
Number of subjects: 368
Study 6398725 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C
Number of subjects: 368
Study 30098945 — intervention group
Group type: EXPERIMENTAL
Intervention: Social exclusion
Number of subjects: 85
Study 26850805 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg of pomegranate extract daily for 30 days
Number of subjects: 48